These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8910391)

  • 21. Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro.
    Fredenburgh JC; Nesheim ME
    J Biol Chem; 1992 Dec; 267(36):26150-6. PubMed ID: 1464625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
    Kim PY; Vu TT; Leslie BA; Stafford AR; Fredenburgh JC; Weitz JI
    J Biol Chem; 2014 Oct; 289(40):27494-503. PubMed ID: 25128532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis.
    Schneider M; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13333-9. PubMed ID: 14715655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
    Bok RA; Mangel WF
    Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.
    Sakharov DV; Nagelkerke JF; Rijken DC
    J Biol Chem; 1996 Jan; 271(4):2133-8. PubMed ID: 8567670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
    Lijnen HR; Van Hoef B; Matsuo O; Collen D
    Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superficial accumulation of plasminogen during plasma clot lysis.
    Sakharov DV; Rijken DC
    Circulation; 1995 Oct; 92(7):1883-90. PubMed ID: 7671373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis.
    Suenson E; Lützen O; Thorsen S
    Eur J Biochem; 1984 May; 140(3):513-22. PubMed ID: 6233145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-affinity binding sites for human Glu-plasminogen unveiled by limited plasmic degradation of human fibrin.
    Tran-Thang C; Kruithof EK; Atkinson J; Bachmann F
    Eur J Biochem; 1986 Nov; 160(3):599-604. PubMed ID: 2946579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.
    Pannell R; Black J; Gurewich V
    J Clin Invest; 1988 Mar; 81(3):853-9. PubMed ID: 2963831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
    Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
    FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis.
    Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of plasmin-mediated degradation on fibrinolysis and tissue plasminogen activator diffusion.
    Bannish BE; Paynter B; Risman RA; Shroff M; Tutwiler V
    Biophys J; 2024 Mar; 123(5):610-621. PubMed ID: 38356261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitro.
    Lijnen HR; Van Hoef B; De Cock F; Collen D
    Blood; 1989 May; 73(7):1864-72. PubMed ID: 2713507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential binding of plasminogen to crosslinked and noncrosslinked fibrins: its significance in hemostatic defect in factor XIII deficiency.
    Sakata Y; Mimuro J; Aoki N
    Blood; 1984 Jun; 63(6):1393-401. PubMed ID: 6232970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of staphylokinase in the acquisition of plasmin(ogen)-dependent enzymatic activity by staphylococci.
    Christner RB; Boyle MD
    J Infect Dis; 1996 Jan; 173(1):104-12. PubMed ID: 8537646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of staphylokinase-dependent plasminogen activation by mono- and divalent ions.
    Yarzábal A; Serrano RL; Puig J
    Braz J Med Biol Res; 1999 Jan; 32(1):39-43. PubMed ID: 10347766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.